Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis.

Abstract

Our data indicate that AR status by ICA may be a useful predictor of survival and endocrine response in prostate cancer. Further studies are needed to confirm these results because the assay could impact significantly on management.